chlorhexidine gluconate and isopropyl alcohol
PREVANTICS MAXI SWABSTICK (chlorhexidine gluconate and isopropyl alcohol) by Becton Dickinson. Approved for bacteria. First approved in 2005.
Drug data last refreshed 13h ago · AI intelligence enriched 2d ago
PREVANTICS MAXI SWABSTICK is a topical antiseptic swab combining chlorhexidine gluconate and isopropyl alcohol for skin antisepsis prior to invasive procedures. It is designed to reduce bacterial colonization and prevent surgical site infections. The product targets healthcare settings where rapid, effective skin preparation is critical.
Product is approaching loss of exclusivity with moderate competitive pressure (30/100), indicating team focus is shifting toward cost management and market defense rather than growth expansion.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Working on PREVANTICS MAXI SWABSTICK offers limited growth trajectory; this is a mature, stable product in a declining phase requiring operational excellence and cost management rather than innovation. Career progression on this product typically leads to defensive portfolio roles or transition to growth-stage assets.
Worked on PREVANTICS MAXI SWABSTICK at Becton Dickinson? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.